Latest Nootropics Stories
LEXINGTON, Massachusetts, March 2, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the company has submitted a New Drug Application (NDA) with
Citizens Commission on Human Rights (CCHR), the leading mental health watchdog, reports that according to IMS Health, there have been steady increases in the number of children 0-5 years old being
LIALDA Patent Case Sent Back to Federal Circuit LEXINGTON, Massachusetts, January 27, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that
LEXINGTON, Massachusetts, January 22, 2015 /PRNewswire/ -- - For Release to US Media Only Shire plc (LSE: SHP, NASDAQ: SHPG) today announces the positive
KP415 is Designed as an Abuse-Deterrent, Controlled Release Prodrug of Methylphenidate for the Treatment of ADHD CORALVILLE, Iowa, Dec.
SAN JOSE, Calif., Dec.
LEXINGTON, Massachusetts, December 1, 2014 /PRNewswire/ -- Company to Profile Key Late-Stage Assets Projected to Drive $3 Billion in Growth by 2020 Shire
A recent study has highlighted the misuse of prescription drugs among college students in an effort to maintain their focus, prompting Novus Medical Detox to call for better education about the detrimental
TORONTO, Nov. 20, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced that the U.S.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.